STEP 1 and 2 proteomics: semaglutide treatment effect

The Holm-Bonferroni (HB) method was used to assess statistical significance. A P value threshold of 0.05 was used for statistical significance.
The protein sets were derived based on the deCODE cohort including almost 35K participants, and the 5K version of the SomaScan assay. As an example, many of the proteins in the set "BMI_max_down" (those that decrease with higher BMI in deCODE) are increased by treatment with semaglutide in STEP, as expected.